HGH 191aa (Somatropin)
The compound itself.
- Sizes available
- —
- Lab certificate (COA)
- Arrives with shipment
· Research-grade only · Not for human consumption · 21+ ·
Recombinant human GH. Direct injection (somatropin). Pharma-grade.
Mechanism · 191-Amino-acid full-length human growth hormone. Native sequence (somatropin).
Best for. Not for.
Best for
- Documented GH deficiency (FDA-approved indications)
- Pediatric GHD / Turner / SHOX / PWS / SGA / ISS
- Adult-onset GH deficiency
- HIV-associated wasting
Not for
- Active malignancy or cancer history (proliferation risk).
- Acromegaly or uncontrolled diabetes.
- Pregnancy or nursing.
- Active diabetic retinopathy progression.
- Critical illness (acute mortality signal).
Mechanism, dose, ramp, risk.
- Mechanism
- Recombinant human growth hormone (191 amino-acid sequence).Source · PEPVERA editorial
- Target dose
- 2-4 IU / day, subq.Source · PEPVERA editorial
- Ramp
- Cycle 12+ weeks.Source · PEPVERA editorial
- Risks
- Bubble gut, insulin resistance, joint pain.Source · PEPVERA editorial
Compared to its siblings.
HGH 191aa (Somatropin)
Recombinant human GH. Direct injection (somatropin). Pharma-grade.
Pros
- · Sufficient for documented GH deficiency, unlike CJC-1295, ipamorelin, or the tesa-trio stack.
- · FDA-approved across multiple brands (Humatrope, Genotropin, Norditropin).
Cons
- · Exogenous GH bypasses pulsatile physiology and receptor feedback that CJC-1295 preserves.
- · Side-effect load (bubble gut, insulin resistance, joint pain) heavier than ipamorelin's clean profile.
- · Single-axis input versus tesa-trio's multi-axis GHRH + GHRP synergy.
CJC-1295
GHRH analog. Endogenous pulse versus exogenous GH.
Pros
- · Physiologic pulse.
- · Receptor feedback intact.
Cons
- · Lower efficacy. Insufficient for documented GH deficiency.
See CJC-1295 →
Ipamorelin
GHRP arm. Pure pulse when stacked with CJC.
Pros
- · Cleaner side effects.
Cons
- · Insufficient for severe GH deficiency.
See Ipamorelin →
Tesamorelin + Ipamorelin + CJC-1295 Trio
GHRH + GHRP triple stack. Synergistic alternative.
Pros
- · Multi-axis stimulation.
Cons
- · Insufficient for documented GH deficiency.
See Tesamorelin + Ipamorelin + CJC-1295 Trio →
COA per supplier
Published, in-house, or shipment-time
Each supplier declares its own HPLC floor and COA policy. The per-supplier verifier appears on the certificate page; refund and shipping terms vary by supplier and are shown on the supplier listing.
Compare 0 suppliers
No verified suppliers yet for this compound.
Direct from foundry. Slower than domestic resellers; consistency is the trade. Insulated packaging, tracked from departure to doorstep. Replacement issued on damage.
Risk
Bubble gut, insulin resistance, joint pain. These pass with discipline. They do not pass with bravado.
Source · PEPVERA editorialDiscipline
Cycle 12+ weeks.
Source · PEPVERA editorialWellness
Hydrate. Eat protein. Sleep eight. Hold a dose for at least two weeks before ascending.
Anti-patterns
- · Do not pair with stimulants late in the day.
- · Do not break the cycle without a planned taper.
- · Do not exceed the dose to chase a deeper sleep response.
Crisis
If the ramp triggers severe anxiety, anhedonia, or persistent gastrointestinal disturbance, stop. Resume after two weeks at half the prior dose. The discipline is the slow climb.
Week 1–2
2-4 IU / day, subq.
Initiation
Week 3–4
2-4 IU / day, subq.
Signal emerges
Week 5–8
2-4 IU / day, subq.
Hold
Week 9–12
Cycle review
Assess
Draw 20 units.
1 mg = 0.20 mL at 5.00 mg/mL. 10.0 doses per vial.
apex · VII
HGH 191aa (Somatropin) · 10mg